Clinical Trial Update: Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating chidamide in combination with carboplatin and paclitaxel for advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• HBI-8000
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: Non-small-cell Lung Cancer | Phase 2 | Status: COMPLETED